ESC Premium Access

Registries atrial fibrillation

Event: ESC CONGRESS 2016
Topic: Atrial fibrillation (AF)
Session type: Registry Session
Date: 29 August 2016
Time: 08:30 - 10:00

Congress Session

6 presentations in this session

Identifying patients with atrial fibrillation and "truly low" thromboembolic risk who are poorly characterized by CHA2DS2-VASc: Superior performance of a novel machine learning tool in GARFIELD-AF

Speaker: Professor K. Fox (Edinburgh, GB)

A nationwide register study to compare bleeding rates in patients with non-valvular atrial fibrillation prescribed oral anticoagulants

Speaker: Professor S. Halvorsen (Oslo, NO)

ESC-EURObservational Research Programme: In-hospital and 1-year follow-up of the Long-term Atrial Fibrillation Ablation Registry, Conducted by the European Heart Rhythm Association

Speaker: Associate Professor E. Arbelo (Barcelona, ES)

XAPASS: Evidence of Safety and Effectiveness in Japanese Patients Treated with Rivaroxaban for Stroke Prevention in Atrial Fibrillation under Real-World Clinical Practice

Speaker: Professor T. Ikeda (Tokyo, JP)

Association of Inappropriate Dosing of Non-Vitamin K Oral Anticoagulants and Risk of Adverse Events: Results from the ORBIT-AF II Registry

Speaker: Associate Professor J. Piccini (Durham, US)

A Large-Scale Multi-Center Registry of Patients Undergoing Radiofrequency Catheter Ablation for Atrial Fibrillation: Kansai Plus Atrial Fibrillation Study

Speaker: Doctor S. Shizuta (Kyoto, JP)

6 speakers from this session

Professor Keith Fox

University of Edinburgh, Edinburgh (United Kingdom of Great Britain & Northern Ireland)
36 presentations
0 follower

Professor Sigrun Halvorsen

Oslo University Hospital Ulleval, Oslo (Norway)
20 presentations
0 follower

Associate Professor Elena Arbelo

Hospital Clinic, University of Barcelona, Barcelona (Spain)
16 presentations

Professor Takanori Ikeda

Toho University, Tokyo (Japan)
1 presentation
0 follower

Associate Professor Jonathan Piccini

Duke University Medical Center, Durham (United States of America)
4 presentations
0 follower

Doctor Satoshi Shizuta

Kyoto University Graduate School of Medicine, Kyoto (Japan)
1 presentation
0 follower

This platform is supported by

logo Novo Nordisk